Alyeska Investment Group’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-50,000	Closed	-$913K	–	902
2021 Q1	$913K	Buy	+50,000	New	+$913K	0.01%	591